Seer Inc. Class A Common Stock (SEER)
Stock · NASDAQ · Industrials
$2.03as of 10/16/2026
Price chart
Active signals
SEER Signal Track Record
How signals performed across all stocks →What SEER's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 40 | -1.3% | 48% | October 5, 2026 |
| Bollinger Band Breakdown | 22 | +3.5% | 55% | September 23, 2026 |
| Bollinger Band Breakout | 21 | -7.5% | 29% | September 28, 2026 |
| 200-Day Moving Average TouchActive now | 14 | -11.9% | 29% | September 14, 2026 |
| Any 20-session window (baseline) | -2.9% | 42% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About SEER
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform p…
- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Employees
- 124
- Website
- seer.bio/
Fundamentals
- 1-day range
- $2.01$2.1
- Market cap
- $120.41M
- P/E (trailing)
- —
- P/E (forward)
- -1.92
- EPS (trailing)
- $-1.22
- Dividend yield
- —
- Beta
- 1.41
- Avg. volume
- 469.0K
How Seer Inc. Class A Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 2, 2026 · via SEC EDGAR / Finnhub
Forecasts
1 analyst ratings
Seer Inc. Class A Common Stock Competitors
Chosen by industry and closest market cap.
- SEERSeer Inc. Class A Common Stock$2.03▼ 0.49%Market cap $120.41MP/E —$1.55$2.41
- NAUTNautilus Biotechnology Inc. Common Stock$2.06▼ 4.63%Market cap $112.76MP/E —$0.8399$4.31
- RPIDRapid Micro Biosystems Inc. Class A Common Stock$0.764▼ 9.59%Market cap $96.03MP/E —$0.8087$4.94
- CIRCCircle8 Group Inc. Common Stock$0.302▼ 5.33%Market cap $70.73MP/E —$0.3132$0.98
- QTRXQuanterix Corporation Common Stock$2.87▼ 6.51%Market cap $180.42MP/E —$2.15$8.77
- PRPOPrecipio Inc. Common Stock$21.38▼ 5.17%Market cap $41.93MP/E —$16.4$33.63
- HBIOHarvard Bioscience Inc. Common Stock$8.09▼ 2.65%Market cap $27.92MP/E —$3.75$9.4
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| SEER Seer Inc. Class A Common Stock | $120.41M | — | $2.03 | ▼ 0.49% | $1.55$2.41 |
| NAUT Nautilus Biotechnology Inc. Common Stock | $112.76M | — | $2.06 | ▼ 4.63% | $0.8399$4.31 |
| RPID Rapid Micro Biosystems Inc. Class A Common Stock | $96.03M | — | $0.764 | ▼ 9.59% | $0.8087$4.94 |
| CIRC Circle8 Group Inc. Common Stock | $70.73M | — | $0.302 | ▼ 5.33% | $0.3132$0.98 |
| QTRX Quanterix Corporation Common Stock | $180.42M | — | $2.87 | ▼ 6.51% | $2.15$8.77 |
| PRPO Precipio Inc. Common Stock | $41.93M | — | $21.38 | ▼ 5.17% | $16.4$33.63 |
| HBIO Harvard Bioscience Inc. Common Stock | $27.92M | — | $8.09 | ▼ 2.65% | $3.75$9.4 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Seer and Nanyang Technological University to Present Early Findings from Landmark PRECISE-SG100K Proteomics Study at HUPO 2026Yahoo · 9/23/2026
- Seer Announces President And CFO David Horn To Depart October 1; Appoints Charles Endweiss As Principal Financial Officerbenzinga · 9/21/2026
- Seer Announces CFO TransitionYahoo · 9/21/2026
- Seer Announces Resignation Of President And CFO David Horn Effective October 1; Appoints Charles Endweiss As Principal Financial OfficerBenzinga · 9/18/2026
- Seer Surpasses 100 Peer-Reviewed Customer Publications, Validating a New Era of Deep Proteomics at ScaleYahoo · 9/16/2026
Insider Activity
Insider Actions →- Horn David R. · August 18, 2026 · Sale7.3K @ $2.03
- Nishar Dipchand · July 28, 2026 · Grant25.0K
- Gulyani Meeta · July 28, 2026 · Grant25.0K
- Gulyani Meeta · July 28, 2026 · Grant16.5K
- Ro Isaac · July 28, 2026 · Grant18.8K
- Ro Isaac · July 28, 2026 · Grant12.4K
- Nishar Dipchand · July 28, 2026 · Grant16.5K
- Roelofs Nicolas H PHD · July 28, 2026 · Grant25.0K
- Roelofs Nicolas H PHD · July 28, 2026 · Grant16.5K
- LANGER ROBERT · July 28, 2026 · Grant25.0K
- LANGER ROBERT · July 28, 2026 · Grant16.5K
- Terrance McGuire · July 28, 2026 · Grant25.0K
- Terrance McGuire · July 28, 2026 · Grant16.5K
- Nishar Dipchand · July 8, 2026 · Sale10.7K @ $2.18
- Horn David R. · May 20, 2026 · Sale7.3K @ $1.69
Institutional Ownership
March 31, 2026
- Total shares held
- 21.03M
- Total value held
- $31.56M
- Institutional holders
- 54
- Unknown5.14M
- Unknown2.46M
- Unknown2.07M
- Unknown1.96M
- Unknown1.82M
- Unknown976.7K
- Unknown825.0K
- Unknown816.4K
- Unknown511.6K
- Unknown459.4K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
Seer to Present Proteomics Data at HUPO 2026; CFO Transition Announced
Seer Inc. will share early results from its PRECISE-SG100K proteomics study with Nanyang Technological University at the HUPO 2026 conference. The company also announced a transition in its Chief Financial Officer role. These developments provide updates on the firm's scientific progress and leadership structure.
Seer to Present Proteomics Data at HUPO 2026; CFO Transition Announced. Seer Inc. will share early results from its PRECISE-SG100K proteomics study with Nanyang Technological University at the HUPO 2026 conference. The company also announced a transition in its Chief Financial Officer role. These developments provide updates on the firm's scientific progress and leadership structure.